Metformin
Glucophage
Metformin (Glucophage) is a longevity & bioregulators research compound. A biguanide that inhibits mitochondrial complex I, activates AMPK and suppresses hepatic gluconeogenesis. The geroscience interest comes from cohort observations and from the AMPK/mTOR axis; the TAME trial was designed to test the ageing claim directly.
Metformin quick facts
| Reported research dose | 500mg-2000mg |
| Route | Oral |
| Frequency | 1-2x Daily |
| Half-life | ~6 hrs (IR) / ~17 hrs (XR) |
| Forms | Oral |
| Evidence level | Extensive human data (diabetes); ageing claim unproven |
Established, cheap and genuinely good for its actual indication. Two honest caveats for the longevity crowd: it DEPLETES B12 — check it annually and check MMA if borderline, because this gets missed for years and presents as fatigue and neuropathy. And there's reasonable evidence it BLUNTS resistance-training adaptations and the aerobic response to exercise, which is an awkward trade if training is the rest of your plan. Prescription only.
How Metformin works
A biguanide that inhibits mitochondrial complex I, activates AMPK and suppresses hepatic gluconeogenesis. The geroscience interest comes from cohort observations and from the AMPK/mTOR axis; the TAME trial was designed to test the ageing claim directly.
Proposed benefits
Researched for mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
✅ Clinically validated
- One of the most-studied drugs in medicine, first-line for type 2 diabetes worldwide for over sixty years. UKPDS showed reduced diabetes-related endpoints and all-cause mortality in overweight diabetics, and the Diabetes Prevention Program showed it reduced progression from prediabetes to diabetes by 31% — though lifestyle intervention beat it at 58%.
- The longevity use is not proven. The TAME trial, designed specifically to test metformin as an ageing intervention in non-diabetics, has struggled for funding and has not reported. The observational claim that diabetics on metformin outlive non-diabetics has been challenged on methodological grounds and is not settled.
- One finding worth knowing before stacking it with training: a randomised trial in older adults found metformin *blunted* the gains in muscle mass from resistance exercise.
📊 Correlative data
- Enormous real-world record. GI effects are the common limitation and largely dose- and formulation-dependent — extended-release is substantially better tolerated. Long-term use depletes B12 and periodic testing is a reasonable habit rather than a precaution.
- Lactic acidosis is the feared risk and is genuinely rare, concentrated in people with significant renal impairment.
🧪 Theoretical / extrapolated
- Inhibits mitochondrial complex I, raising the AMP:ATP ratio and activating AMPK — which suppresses hepatic gluconeogenesis, the main source of its glucose-lowering effect. It also acts on the gut microbiome and increases GDF15, which may explain part of the appetite effect.
- AMPK activation opposes mTOR, which is the mechanistic basis for both the longevity interest and the blunted training adaptation. They are the same mechanism read two ways — suppressing growth signalling is protective against age-related damage and directly counterproductive when you are trying to build muscle.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
Metformin — safety, predicted from mechanism
Much of this compound class has never been through a human safety trial. Rather than say nothing — or print a generic warning — this is what its known mechanism predicts could go wrong, and what you can do about it. Predictions are labelled as predictions.
What the mechanism predicts
Derived from what this molecule does, not from a trial.
- These are short peptide fragments of organ extracts, and the honest starting point is that the mechanism itself is not established in a way that lets anyone predict harm precisely. The proposal is gene-regulatory — short peptides binding DNA and modulating transcription in a tissue-specific way. If that is what they do, the theoretical concern is influencing transcription in tissue you were not aiming at.
- In practice the doses are tiny, the peptides are short, and they are degraded quickly — which is also the argument that they may do very little at all. Those two possibilities are the same uncertainty viewed from opposite ends, and you should hold both.
What has actually been reported
- Decades of Russian clinical use with a strikingly clean tolerability record — injection-site reactions and little else reported.
- That record comes almost entirely from one research school, is largely unreplicated outside it, and safety data from a group with an interest in the outcome is worth less than the same data from a sceptic. This is not an accusation; it is how evidence weighting works.
How to reduce the risk
Each of these follows from the same mechanism as the prediction.
- Follow the course printed on the label rather than running continuously. These are the one class in the Vault where a duration is STATED rather than inferred, and it is typically 10–20 days repeated a few times a year. Read the box.
- Run one at a time. They are cheap and it is tempting to stack six. If something changes, a stack of six tells you nothing about which one did it — and given the evidence base, attribution is the entire value of your own experiment.
- Decide your endpoint before you start, and make it a marker or a measurable symptom rather than a feeling. With a compound class this under-evidenced, an unfalsifiable endpoint means you will conclude it worked no matter what happened.
- Buy from a source that publishes third-party testing. Where the molecule itself is uncertain, identity and purity are the only variables you can actually control.
What it does to your bloodwork
A fact about the assay, not a guess about the drug.
- Test the ORGAN, not the peptide. A thymic peptide is judged on immune markers, a pineal one on sleep and IGF-1, a vascular one on lipids and inflammatory markers. There is no assay for the compound itself.
Don't run this if
- Pregnancy — not because of a specific finding, but because nobody has studied it and the mechanism claim is transcriptional.
- Active malignancy, on the same reasoning as any tissue-growth signal: unproven, mechanistically arguable, and not worth finding out.
The honest unknown
- Essentially everything a sceptic would want: independent replication, pharmacokinetics, and whether the oral forms survive digestion at all. Unproven is not the same as ineffective — but here it is a large unproven.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
Where to get Metformin
Buy Metformin at AlgoRx →Metformin — interference & stacking
Predicted from mechanism, not from an interaction study. There are no trials of these combinations — what follows is what the biology implies, so treat it as a reason to watch something, not as a finding.
What Metformin moves on your bloodwork
These are the markers this compound is expected to move, and which direction. Knowing that in advance is mostly about NOT panicking: some of these moving is the compound working.
- hs-CRP (High-Sensitivity C-Reactive Protein) — ↓ expected to fall
Where these work, systemic inflammation is the plausible readout.
What to do: hs-CRP is cheap and moves. Baseline and 12 weeks. - HbA1c (Hemoglobin A1c) — ↓ expected to fall
Improved mitochondrial and metabolic function should show here if the effect is real at all.
What to do: The honest use of these markers is as a falsification test: if nothing moves in 12 weeks, the compound is not doing much for you. - Comprehensive Metabolic Panel (CMP) — ◆ worth watching
Liver and kidney function — the standard baseline for anything run long term.
What to do: Twice a year is enough on a stable protocol.
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Get the complete breakdown for Metformin — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →This class is where honest expectation-setting matters most: the markers above are how you find out whether anything happened, and for most of these compounds that question is genuinely open.
- How to work up to it, and when not to
- When to take it, and why that window
- Cycle length
- Time off between cycles
- Fasted or fed, and when in the day
- Coach Cam's personal notes
Get the complete breakdown for Metformin — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →Bloodwork to run alongside Metformin
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| hs-CRP (High-Sensitivity C-Reactive Protein) | Chronic low-grade inflammation is the process most of these target |
| ApoB (Apolipoprotein B) | Counts the particles that actually cause plaque, unlike LDL-C |
| HbA1c (Hemoglobin A1c) | Glycation, which is the other half of the ageing story |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney — the two organs that clear everything you take |
| Complete Blood Count (CBC) with Differential | The cheapest broad screen there is |
The Longevity Baseline panel covers these in one order — 13 markers, $219.10 with the discount applied.
Check results you already have → · All 102 markers A–Z
Metformin — frequently asked questions
What is Metformin?
Metformin (Glucophage) is a longevity & bioregulators research compound. A biguanide that inhibits mitochondrial complex I, activates AMPK and suppresses hepatic gluconeogenesis. The geroscience interest comes from cohort observations and from the AMPK/mTOR axis; the TAME trial was designed to test the ageing claim directly.
Is the full Metformin protocol on this page?
The reported research dose is on this page, along with how Metformin works and the evidence behind it. The protocol — how to work up to it, frequency, cycle length, time off, what not to stack it with and Coach Cam's notes — is inside the Academy.
What is the half-life of Metformin?
Metformin has an approximate half-life of ~6 hrs (IR) / ~17 hrs (XR), which is part of what determines how often it's dosed.
What's the evidence behind Metformin?
Current evidence level: Extensive human data (diabetes); ageing claim unproven. Metformin is offered for research purposes only and is not an approved medicine.
Want Coach Cam's exact Metformin protocol?
Dosing schedules, stacking, cycle timing and my personal notes live inside the Academy — plus the full interactive Vault of 237 compounds & 350 supplements.
Join the Academy — $10/mo →What Metformin is used for
Metformin appears under 4 goals in the Vault’s goal router, grouped by the mechanism it works through rather than by how much trial evidence exists. Each link opens that pathway in full, with the alternatives beside it and the bloodwork that tests it.